Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

Stock performance could be a risk versus reward assessment. Current risk is a doozie: if MNTA is not able to get approval for mCopax as the market seems to be suggesting, the company may not exist in 5 years. Even if it does, not in its current form and probably worth pennies on the dollar.

mCopax approval could be an all or nothing proposition for the company's survival and that's a scary proposition. The longer the wait goes, the scarier it gets